Six winners have been selected across six categories: Public Health, Full Time Clinician, New RDH, Research, Academia and Entrepreneur - including three US winners
The World Dental Hygienist Awards ceremony will be held at the 2026…
Read More...
AB 1952 Showdown: Dental Professions Divided Ahead of Critical Vote
With a pivotal vote days away, AB 1952 has sparked a major divide between CDA and CDHA, raising urgent questions about workforce…
Fluoride Is Cleared by Science but Supply Threats Raise New Concerns
A landmark long-term study confirms fluoridated water is safe for brain health, yet geopolitical disruptions are now putting access…
NYU Dentistry Receives $5M to Expand Oral Health Care for Children with…
State funding will create dedicated space for pediatric and adolescent care and improve access for people with disabilities across…
New ASTDD Foundation Will Expand Investment in Oral Health Leadership and…
Victor, NY, April 10, 2026 — The Association of State and Territorial Dental Directors (ASTDD) today announced the official launch…
Weekly Popular
Personal Finance
More Top Stories
Presence of Gene Increases Risk of Severe COVID-19 Illness
One of the most significant unanswered questions of the global pandemic is why some people experience mild symptoms while others become seriously ill and even die. The answer may be in our genes. Researchers from the United Kingdom have…
Pfizer to Seek FDA Approval for Its COVID-19 Antiviral Medication
On the heels of the United Kingdom’s authorization of a competing medication by Merck, Pfizer announced that its own antiviral drug designed to treat COVID-19 shows promising results. According to the company’s clinical trial on 775 adults…
UK Approves Use of Antiviral Medication to Treat COVID-19
The United Kingdom (UK) has authorized the use of an antiviral medication, molnupiravir, to reduce the severity of illness associated with COVID-19. Manufactured by the American pharmaceutical company, Merck, molnupiravir has been shown to…
Is COVID-19 Switching From Pandemic to Endemic?
Many public health experts suggest that the COVID-19 pandemic will come to a close by the end of 2022, and while it will not disappear, the pandemic will mutate into an endemic disease. This change will mean that most people will have…
Pending Legislation Promotes Oral Health Literacy
Federal legislation of interest to the oral health community was recently included in a hearing held by the U.S. House of Representatives’ Energy and Commerce Committee: the Oral Health Literacy and Awareness Act of 2021 (H.R. 4555).…
The Demographics of COVID-19 Continue to Evolve
At the start of the COVID-19 pandemic, it was clear who was at greatest risk for COVID-19-related mortality and morbidity—older adults and those with preexisting conditions such as diabetes, and where—urban centers with dense populations in…
A Sad COVID-19 Milestone Reached: 5 Million People Dead
While the United States is experiencing a much-needed slow down in the number of new COVID-19 cases across the country, a tragic milestone has been met—throughout the globe, more than 5 million people have died due to illness caused by …
New Colgate® Optic White® Professional
New Colgate® Optic White® Professional is extraordinary whitening made simple. Help patients achieve a dramatically whiter smile in just 5 days, when used as directed. ALL-NEW patented technology designed for no tooth sensitivity, no gum…
Myriad Reasons Behind COVID-19 Supply Chain Disaster
An MIT Sloan Management Review article reports that more than one factor caused the COVID-19 supply chain perfect storm. First, consumers and businesses over-ordered goods due to concern about the length of the pandemic lockdown. This…
Inexpensive Antidepressant Medication May Reduce Severity of COVID-19
Research shows that fluvoxaminean, an inexpensive antidepressant medication, decreases the need for hospitalization among high-risk adults with COVID-19. The drug fights inflammation and is traditionally used to address depression and…
Recent Posts
Market Media
- Advertisement -
